Thrombotic thrombocytopenic purpura with the use of efalizumab for psoriasis

British Journal of Dermatology

Volumn 158, Issue 5, 2008, Pages 1138-1139

  Thachil, J ^a   Martlew, V ^a  

^a ROYAL LIVERPOOL UNIVERSITY HOSPITAL   (United Kingdom)

Author keywords

Biological therapy; Efalizumab; Purpura; Thrombotic thrombocytopenic purpura

Indexed keywords

CYCLOSPORIN; EFALIZUMAB; LACTATE DEHYDROGENASE; LYMPHOCYTE FUNCTION ASSOCIATED ANTIGEN 1; METHOTREXATE; VON WILLEBRAND FACTOR CLEAVING PROTEINASE;

ADULT; ANEMIA; CASE REPORT; DRUG EFFICACY; ERYTHRODERMA; FEMALE; HUMAN; LETTER; LYMPHOCYTIC INFILTRATION; PLASMAPHERESIS; PRIORITY JOURNAL; PSORIASIS; THROMBOCYTE AGGREGATION; THROMBOCYTE COUNT; THROMBOCYTOPENIA; THROMBOTIC THROMBOCYTOPENIC PURPURA;

ADULT; ANTIBODIES, MONOCLONAL; FEMALE; HUMANS; IMMUNOLOGIC FACTORS; PLASMA EXCHANGE; PSORIASIS; PURPURA, THROMBOTIC THROMBOCYTOPENIC;

EID: 42049114481     PISSN: 00070963     EISSN: 13652133     Source Type: Journal    
DOI: 10.1111/j.1365-2133.2008.08454.x     Document Type: Letter

References (7)

1. Menter A, Griffiths CE. Current and future management of psoriasis. Lancet 2007 370 : 272 84.
2. Gottlieb A, Krueger JG, Bright R et al. Effects of administration of a single dose of a humanized monoclonal antibody to CD11a on the immunobiology and clinical activity of psoriasis. J Am Acad Dermatol 2000 42 : 428 35.
3. Smith CH, Anstey AV, Barker JN et al. British Association of Dermatologists guidelines for use of biological interventions in psoriasis. Br J Dermatol 2005 153 : 486 97.
4. Rock GA, Shumak KH, Buskard NA et al. Comparison of plasma exchange with plasma infusion in the treatment of thrombotic thrombocytopenic purpura. Comparison of plasma exchange with plasma infusion in the treatment of thrombotic thrombocytopenic purpura. N Engl J Med 1991 325 : 393 7.
5. Tsai HM, Lian EC. Antibodies to von Willebrand factor-cleaving protease in acute thrombotic thrombocytopenic purpura. N Engl J Med 1998 339 : 1585 94.
6. Furlan M, Robles R, Galbusera M et al. Von Willebrand factor- cleaving protease in thrombotic thrombocytopenic purpura and the haemolytic-uraemic syndrome. N Engl J Med 1998 339 : 1578 84.
7. Porta C, Danova M, Riccardi A et al. Cancer chemotherapy-related thrombotic thrombocytopenic purpura: biological evidence of increased nitric oxide production. Mayo Clin Proc 1999 74 : 570 4.